GERARD FERNANDO: Open Payments
NPI 1750645024 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 78 payments from 19 companies in 2025. Trend: 2023 $1,877 · 2024 $1,327 · 2025 $1,516
Food & beverage: $1,417Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $316 |
| Lundbeck LLC | 9 | $176 |
| ABBVIE INC. | 13 | $137 |
| E.R. Squibb & Sons, L.L.C. | 6 | $119 |
| Neurocrine BioSciences, Inc. | 3 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $80 |
| Vanda Pharmaceuticals Inc. | 3 | $75 |
| Bausch Health US, LLC | 3 | $68 |
| Supernus Pharmaceuticals, Inc. | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
Products named: AUSTEDO XR, REXULTI, VRAYLAR, COBENFY, ABILIFY ASIMTUFII, INGREZZA, CAPLYTA, FANAPT.
Industry payments across CA — which companies pay providers there.
